ArticleInfection2025

Comparison of the in vitro activities and resistance mechanisms against imipenem-relebactam and ceftazidime-avibactam in clinical KPC-producing Klebsiella pneumoniae isolated in China.

Yingyi Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.